Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12

Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12

US Patent 10934346 · Granted Mar 2, 2021

Estimated economic value: $556,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Natural killer cell products and methods2025
Method of increasing resistance against soybean rust in transgenic plants by inc2025
Methods for inducing partial apoptosis using caspase polypeptides2023
Methods for inducing partial apoptosis using caspase polypeptides2023
Methods for inducing partial apoptosis using caspase polypeptides2023
Costimulation of chimeric antigen receptors by MYD88 and CD40 polypeptides2021
Costimulation of chimeric antigen receptors by MYD88 and CD40 polypeptides2021
Costimulation of chimeric antigen receptors by MYD88 and CD40 polypeptides2021
Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides2021
Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides2021
Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides2021
Methods for inducing partial apoptosis using caspase polypeptides2020